Bris­tol My­ers joins the lab rush in Cam­bridge with plans to con­sol­i­date R&D ops in a biotech cam­pus now un­der con­struc­tion

Bris­tol My­ers Squibb is fol­low­ing Sanofi on the big trek to a new biotech cam­pus now be­ing built in the boom­ing Cam­bridge, MA bio­phar­ma R&D hub.

The phar­ma gi­ant has inked a 360,000-square-foot lease at Cam­bridge Cross­ing, where the dirt is fly­ing on a sprawl­ing 43-acre life sci­ences hub on the city line be­tween Cam­bridge and Somerville.

Bris­tol My­ers plans to con­sol­i­date its staff in the area, which in­cludes a lo­ca­tion at 100 Bin­ney Street, with plans to move in­to a new build­ing at 250 Wa­ter Street in 2023.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER